Variable | HR (95 % CI) | p |
---|---|---|
RI | ||
UD 10/10 | 0.75 (0.63–0.90) | <0.01 |
UD 9/10 | 0.77 (0.57–1.05) | 0.10 |
Agea | 0.99 (0.99–1.00) | 0.02 |
Time from dx to Tx >9 mo | 0.62 (0.52–0.72) | <0.01 |
Female donor to male recipient | 0.91 (0.74–1.11) | 0.34 |
sAML | 0.99 (0.79–1.23) | 0.92 |
previous auto-HSCT | 1.22 (0.86–1.73) | 0.26 |
Positive recipient CMV serology | 0.96 (0.80–1.15) | 0.68 |
Positive donor CMV serology | 1.03 (0.86–1.22) | 0.77 |
RIC | 1.21 (1.02–1.42) | 0.03 |
NRM | ||
UD 10/10 | 0.97 (0.74–1.29) | 0.86 |
UD 9/10 | 1.32 (0.87–2.00) | 0.19 |
Agea | 1.02 (1.01–1.03) | <0.01 |
Time from dx to Tx >9 mo | 0.81 (0.62–1.04) | 0.10 |
Female donor to male recipient | 0.86 (0.61–1.20) | 0.38 |
sAML | 1.40 (1.04–1.90) | 0.03 |
previous auto-HSCT | 1.50 (0.92–2.45) | 0.10 |
Positive recipient CMV serology | 0.96 (0.72–1.28) | 0.80 |
Positive donor CMV serology | 0.98 (0.75–1.29) | 0.90 |
RIC | 0.96 (0.74–1.25) | 0.78 |
LFS | ||
UD 10/10 | 0.81 (0.70–0.94) | 0.01 |
UD 9/10 | 0.92 (0.72–1.18) | 0.53 |
Agea | 1.00 (0.99–1.00) | 0.82 |
Time from dx to Tx >9 mo | 0.67 (0.58–0.76) | <0.01 |
Female donor to male recipient | 0.89 (0.75–1.07) | 0.21 |
sAML | 1.11 (0.93–1.33) | 0.24 |
previous auto-HSCT | 1.30 (0.98–1.72) | 0.07 |
Positive recipient CMV serology | 0.97 (0.83–1.13) | 0.67 |
Positive donor CMV serology | 1.01 (0.88–1.17) | 0.86 |
RIC | 1.13 (0.98–1.30) | 0.08 |
OS | ||
UD 10/10 | 0.87 (0.74–1.01) | 0.07 |
UD 9/10 | 1.00 (0.78–1.29) | 0.99 |
Agea | 1.00 (1.00–1.01) | 0.36 |
Time from dx to Tx >9 mo | 0.70 (0.61–0.81) | <0.01 |
Female donor to male recipient | 0.85 (0.71–1.03) | 0.09 |
sAML | 1.10 (0.91–1.32) | 0.31 |
previous auto-HSCT | 1.25 (0.93–1.69) | 0.14 |
Positive recipient CMV serology | 0.95 (0.81–1.12) | 0.56 |
Positive donor CMV serology | 0.99 (0.85–1.16) | 0.94 |
RIC | 1.01 (0.88–1.17) | 0.86 |